Gonadal vein tumor thrombus in metastatic renal cell carcinoma

Anil A Thomas1, Brian R Herts, Steven C Campbell

  • 1Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.

Urology
|April 21, 2009
PubMed

Insights

Metastatic renal cell carcinoma rarely invades the gonadal vein. This case highlights a patient with unresectable disease treated with targeted molecular therapy.

Area of Science:

  • Oncology
  • Urology

Background:

  • Renal cell carcinoma (RCC) can invade adjacent vasculature, including the renal vein and inferior vena cava.
  • Such vascular invasion occurs in 4%-10% of RCC patients.
  • However, gonadal vein involvement by RCC is considered uncommon.

Observation:

  • This report details a rare case of unresectable metastatic renal cell carcinoma.
  • The tumor exhibited direct invasion into the gonadal vein.
  • The patient received initial treatment with targeted molecular therapy.

Findings:

  • The case demonstrates gonadal vein invasion as an unusual manifestation of metastatic renal cell carcinoma.
  • It underscores the importance of considering rare metastatic patterns in advanced RCC.
  • Targeted molecular therapy was the initial treatment approach.

Implications:

  • This case expands the understanding of potential metastatic pathways in renal cell carcinoma.
  • It may inform diagnostic considerations and treatment strategies for advanced RCC with unusual venous involvement.
  • Further research could explore the specific mechanisms and clinical outcomes associated with gonadal vein invasion in RCC.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Veins of the Abdomen and Pelvis01:18

Veins of the Abdomen and Pelvis

The human body is a complex system of interconnected parts, and the circulatory system plays a crucial role in maintaining overall health. One key component of this system is the inferior vena cava, a large vein responsible for returning blood from the abdominopelvic viscera and abdominal walls to the heart.
The inferior vena cava is fed by numerous smaller veins. The lumbar veins, for instance, drain the posterior abdominal wall, emptying both directly into the inferior vena cava and into the...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...